KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $208.2 million.

  • Idexx Laboratories' Cash & Current Investments fell 3255.29% to $208.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.2 million, marking a year-over-year decrease of 3255.29%. This contributed to the annual value of $288.3 million for FY2024, which is 3649.58% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Cash & Current Investments is $208.2 million, which was down 3255.29% from $164.6 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Cash & Current Investments ranged from a high of $453.9 million in Q4 2023 and a low of $99.2 million during Q3 2022
  • Moreover, its 5-year median value for Cash & Current Investments was $204.6 million (2022), whereas its average is $229.8 million.
  • Examining YoY changes over the last 5 years, Idexx Laboratories' Cash & Current Investments showed a top increase of 33143.07% in 2021 and a maximum decrease of 6237.47% in 2021.
  • Quarter analysis of 5 years shows Idexx Laboratories' Cash & Current Investments stood at $144.5 million in 2021, then fell by 22.09% to $112.5 million in 2022, then skyrocketed by 303.33% to $453.9 million in 2023, then plummeted by 36.5% to $288.3 million in 2024, then decreased by 27.79% to $208.2 million in 2025.
  • Its last three reported values are $208.2 million in Q3 2025, $164.6 million for Q2 2025, and $164.0 million during Q1 2025.